NCT04370496 Safety of Minimally Invasive Surgery Using Endoscopic Stapler in Early Stage Cervical Cancer Patients (SOLUTION) Status RECRUITING Phase NA
NCT04368273 Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer. Status UNKNOWN Phase PHASE1/PHASE2
NCT04368130 SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care Status WITHDRAWN Phase NA
NCT04312178 Combined Incentive Actions, Focusing on Primary Care, to Improve Cervical Cancer Screening in Women Residing in Socio-economically Disadvantaged and Untracked Geographical Areas: a Hybrid Efficacy and Implementation Trial Status COMPLETED Phase NA
NCT04310774 CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT04301011 Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors Status TERMINATED Phase PHASE1
NCT04300647 A Study of Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or Recurrent PD-L1-Positive Cervical Cancer Status COMPLETED Phase PHASE2
NCT04287868 Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04286243 Prevention of Cervical Cancer Through an HPV-based Screen-and-treat Strategy in Malawi Status COMPLETED Phase NA
NCT04278326 Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments Status TERMINATED Phase NA
NCT04275713 Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC Status COMPLETED Phase PHASE2
NCT04274465 Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia Status COMPLETED Phase N/A
NCT04272190 Effect of Different Treatments on the Prognosis of Early Cervical Cancer: A Multicenter, Prospective, Real-world Study Status RECRUITING Phase N/A
NCT04272034 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT04260802 A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers Status TERMINATED Phase PHASE1/PHASE2